---
category: news
title: "Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis"
excerpt: "Therapixel, a company leading the use of AI-based products for women's health, announces it has received a second 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for MammoScreen®, the explainable and actionable Artificial Intelligence (AI) based software assisting Radiologists in breast cancer screening."
publishedDateTime: 2021-11-28T13:10:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/therapixel-receives-fda-clearance-for-use-of-its-ai-based-breast-cancer-screening-software-mammoscreen-on-digital-breast-tomosynthesis-1031007040"
webUrl: "https://markets.businessinsider.com/news/stocks/therapixel-receives-fda-clearance-for-use-of-its-ai-based-breast-cancer-screening-software-mammoscreen-on-digital-breast-tomosynthesis-1031007040"
type: article
quality: 35
heat: 35
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1697346/Logo_Therapixel__1.jpg"
    width: 400
    height: 400
    isCached: true

secured: "c0sejhef4Ip48GlUPoaPhoZrHIkT/YmbysR85Be7ISQNA04z6lCJpM3nKYQEJzvQn1NQjJ1hxTOMPzk+1RI8lDPStptj0GTdlAMVBXwz5cRB2R4NYh8lZrtF+V82wQRJFoLbBpB4GNnAG6y+7DaoOCtFFb3Q/S8qa1ikMmSgwfcR1jyEwTAwj9Fa5worhDJLEOLYSb33C9lq8kpi5eFihFu90u+4g9uIZi/B16dMfz0ZSIUai+hl9skSxjzHtPy63Trp1RWvHa0SRr7xJNyPgCW6CqbkQZ569O6DdlQ7BMweYH+sAb8E5ooscShSg4rIu7tVy42nm0nBNez2RHFWEJOVUXti6L9G5xbfFhM5OtA=;AxzyACK5/OvROL+H2iML1Q=="
---

